Response characteristics to antidepressants and placebo in post- traumatic stress disorder

International Clinical Psychopharmacology

Volumn 12, Issue 6, 1997, Pages 291-296

  Davidson, J R T ^a   Malik, M L ^a   Sutherland, S N ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antidepressants; Placebo; PTSD; Response

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BROFAROMINE; FLUOXETINE; IMIPRAMINE; PHENELZINE; PLACEBO;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; POSTTRAUMATIC STRESS DISORDER; PREDICTION; PRIORITY JOURNAL; RATING SCALE; REVIEW; TREATMENT OUTCOME;

EID: 0031426430     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199711000-00001     Document Type: Review

References (9)

1. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. American Psychiatric Association, Washington.
2. Baker DG, Diamond BI, Gillette G, Hamner M, Katzelnick D, Keller T, Mellman TA, Pontius E, Rosenthal M, Tucker P et al. (1995) A double-blind, randomized placebo-controlled multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology, 122, 386-389.
3. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Lawrence Erlbaum Associates, Publishers, Hillsdale, New Jersey.
4. Davidson JRT, Kudler HS, Smith RD, Mahorney SL, Lipper S, Hammett EB, Saunders WB and Cavenar JO (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259-266.
5. Katz RJ, Lott MH, Arbus P, Crocq L, Harlobsen P, Lingjaerde O, Lopez G, Loughery GC, MacFarlane DJ, McIvor R et al. (1995) Pharmacotherapy of posttraumatic stress disorder with a novel psychotropic. Anxiety, 1, 169-174.
6. Kosten TR, Frank JB, Dan E, McDougle CJ and Giller EL Jr. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. Journal of Nervous and Mental Disease, 179, 366-370.
7. Parker G (1996) On brightening up: triggers and trajectories to recovery from depression. British Journal of Psychiatry, 168, 263-264.
8. Stassen HH, Delini-Stula A and August J (1993) Time course of improvement under antidepressant treatment: a survival-analytical approach. European Neuropsychopharmacology, 3, 127-135.
9. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz B, Fisher R and Saxe G (1994) Fluoxetine in posttraumatic stress disorder. Journal of Clinical Psychiatry, 55, 517-522.